Meningococcal B vaccine (4CMenB): the journey from research to real world experience

Introduction: Neisseria meningitidis serogroup B (MenB) is the most common cause of bacterial meningitis in many industrialized countries and occurs at any age. The highest incidence is in infants aged <1 year, followed by children and adolescents. Four-component MenB vaccine (4CMenB, Bexsero) is...

Full description

Bibliographic Details

Published in:	Expert Review of Vaccines
Main Authors:	Rino Rappuoli, Mariagrazia Pizza, Vega Masignani, Kumaran Vadivelu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-12-01
Subjects:	4cmenb effectiveness infants; adolescents impact meningococcal serogroup b neisseria meningitidis neisseria gonorrhoeae vaccine
Online Access:	http://dx.doi.org/10.1080/14760584.2018.1547637